Genetic markers in the blood of four Italian horse breeds.

This research article provides an overview of genetic relationships among four horse breeds native to Italy: Maremmana, Sanfratellana, Sardinian-Anglo-Arabian, and Giara.

Overview of Italian Horse Breeds

• The study focuses on four horse breeds indigenous to Italy: Maremmana, Sanfratellana, Sardinian-Anglo-Arabian, and Giara. Each breed has distinct characteristics influenced by their genetic heritage and crossbreeding with other types of horses.

Maremmana Breed

• The Maremmana horse originated from Central European breeds and has been crossbred with the Thoroughbred. About 2,000 Maremmana horses are concentrated in the area between Pisa and Rome. These horses are primarily used for sports, including steeplechase, cross-country, and hurdle races, as well as ordinary horseback riding.

Sanfratellana Breed

• The Sanfratellana horse breed partially descends from Arabian horses. Crossbreeding with the Maremmana is common for this breed, which inhabits the eastern part of Sicily. The Sanfratellana population is relatively small, with approximately 800 animals. They are also primarily used for sports.

Sardinian-Anglo-Arabian Breed

• The Sardinian-Anglo-Arabian breed is the result of crossing French Anglo-Arabian and Thoroughbred horses with Arabian-derived Sardinian horses. With a population of about 2,000, it is the most significant breed in Sardinia. Sardinian-Anglo-Arabians are often used in horse racing and general riding.

Giara Breed

• The Giara horse, a type of pony, lives wild in central Sardinia. It has minimal influence from other horse breeds, and its primary use is for meat production. The Giara horse population consists of around 700 animals.

Implications of the Research

• The research’s findings about these horse breeds can contribute to understanding their history, development, and current usage. Information about genetic markers in their blood also provides insight into the effects of crossbreeding on these animals’ characteristics and potential risks of genetic diseases.